BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36811232)

  • 21. The expanding role of RNA modifications in plant RNA polymerase II transcripts: highlights and perspectives.
    Zimna M; Dolata J; Szweykowska-Kulinska Z; Jarmolowski A
    J Exp Bot; 2023 Aug; 74(14):3975-3986. PubMed ID: 37076273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m
    Shi Y; Xiong X; Sun Y; Geng Z; Chen X; Cui X; Lv J; Ge L; Jia X; Xu J
    FASEB J; 2023 Oct; 37(10):e23183. PubMed ID: 37665628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA m6A methylation regulators in ovarian cancer.
    Guo J; Zheng J; Zhang H; Tong J
    Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational Regulation by eIFs and RNA Modifications in Cancer.
    Zhang L; Zhang Y; Zhang S; Qiu L; Zhang Y; Zhou Y; Han J; Xie J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer.
    Wang J; Wu A; Yang B; Zhu X; Teng Y; Ai Z
    Gene; 2020 Jan; 724():144150. PubMed ID: 31589961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives.
    Imbriano C; Moresi V; Belluti S; Renzini A; Cavioli G; Maretti E; Molinari S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of m
    Yang C; Hu Y; Zhou B; Bao Y; Li Z; Gong C; Yang H; Wang S; Xiao Y
    Cell Death Dis; 2020 Nov; 11(11):960. PubMed ID: 33162550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics in ovarian cancer.
    Natanzon Y; Goode EL; Cunningham JM
    Semin Cancer Biol; 2018 Aug; 51():160-169. PubMed ID: 28782606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance.
    Wood S; Willbanks A; Cheng JX
    Curr Cancer Drug Targets; 2021; 21(4):326-352. PubMed ID: 33504307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic regulations in mammalian spermatogenesis: RNA-m
    Gui Y; Yuan S
    Cell Mol Life Sci; 2021 Jun; 78(11):4893-4905. PubMed ID: 33835194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S
    J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation modifications in eukaryotic messenger RNA.
    Liu J; Jia G
    J Genet Genomics; 2014 Jan; 41(1):21-33. PubMed ID: 24480744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Messenger RNA modifications: Form, distribution, and function.
    Gilbert WV; Bell TA; Schaening C
    Science; 2016 Jun; 352(6292):1408-12. PubMed ID: 27313037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA modifications in cancer.
    Tang Q; Li L; Wang Y; Wu P; Hou X; Ouyang J; Fan C; Li Z; Wang F; Guo C; Zhou M; Liao Q; Wang H; Xiang B; Jiang W; Li G; Zeng Z; Xiong W
    Br J Cancer; 2023 Aug; 129(2):204-221. PubMed ID: 37095185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mark of disease: how mRNA modifications shape genetic and acquired pathologies.
    Destefanis E; Avşar G; Groza P; Romitelli A; Torrini S; Pir P; Conticello SG; Aguilo F; Dassi E
    RNA; 2021 Apr; 27(4):367-389. PubMed ID: 33376192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases.
    Willbanks A; Wood S; Cheng JX
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.